Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/279790
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey |
Autor: | Hoste, Levi; MIS-C researchers; Soriano-Arandes, Antoni; Buddingh, Emilie Pauline; Belot, Alexandre; Ulloa-Gutiérrez, Rolando; Olbrich, Peter CSIC ORCID CVN; Haerynck, Filomeen | Palabras clave: | MIS-C SARS-CoV-2 COVID-19 Vaccinationadverse events |
Fecha de publicación: | sep-2022 | Editor: | Elsevier | Citación: | Journal of Pediatrics 248: 114-118 (2022) | Resumen: | The optimal severe acute respiratory syndrome coronavirus 2 vaccine strategy for patients with a history of multisystem inflammatory syndrome in children (MIS-C) is unclear. We performed an international survey (32 countries) and found substantial variations in vaccine policies. Respondents did not report relapses of MIS-C or other severe inflammatory side effects after severe acute respiratory syndrome coronavirus 2 vaccination in 273 patients with a history of MIS-C. | Versión del editor: | https://doi.org/10.1016/j.jpeds.2022.05.028 | URI: | http://hdl.handle.net/10261/279790 | DOI: | 10.1016/j.jpeds.2022.05.028 | ISSN: | 0022-3476 |
Aparece en las colecciones: | (PTI Salud Global) Colección Especial COVID-19 (IBIS) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children.pdf | 646,84 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
13
checked on 22-abr-2024
WEB OF SCIENCETM
Citations
11
checked on 24-feb-2024
Page view(s)
51
checked on 02-may-2024
Download(s)
44
checked on 02-may-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.